Related Experiment Videos
Generalisability of results from randomised drug trials. A trial on antimanic treatment
R W Licht1, G Gouliaev, P Vestergaard
1Institute for Basic Psychiatric Research, Department of Psychiatric Demography, Psychiatric Hospital in Aarhus, Denmark.
Background:
Exemplified by a randomised trial on antimanic treatment, this paper addresses the question of whether selection of patients for drug trials may limit the applicability of study results from the randomised patients to a wider population.
Method:
During two-year period, all consecutively admitted patients from a defined catchment area were screened for inclusion criteria concerning age, diagnosis and severity of illness. The subsequently excluded subgroups of patients were compared with the randomised patients by multivariate data analysis.
Results:
One hundred and sixty-four patients met the inclusion criteria. However, after exclusion for various reasons, only 27 (17%) patients remained for randomisation. The randomised patients and the excluded patients differed substantially.
Conclusions:
The generalisability of trial results is limited. Reports of randomised drug trials should carefully describe the screening procedure for inclusion and, when possible, present relevant comparisons-between the randomised patients and the various subgroups of excluded patients.
Insights
Patient selection in drug trials significantly limits generalizability. Comparing randomized patients with excluded groups is crucial for understanding broader applicability in clinical research.
Area of Science:
- Clinical Research Methodology
- Psychiatric Drug Trials
Background:
- Investigates patient selection bias in randomized controlled trials (RCTs).
- Uses a randomized trial on antimanic treatment as a case study.
- Addresses the limited applicability of study results to wider patient populations.
Purpose of the Study:
- To determine if patient selection in drug trials restricts the generalizability of findings.
- To highlight the importance of understanding excluded patient groups.
Main Methods:
- Screened consecutively admitted patients from a defined area over two years.
- Applied inclusion criteria for age, diagnosis, and illness severity.
- Compared excluded patient subgroups with randomized patients using multivariate analysis.
Main Results:
- 164 patients met initial inclusion criteria.
- Only 27 (17%) patients were ultimately randomized after exclusions.
- Significant differences were observed between randomized and excluded patient groups.
Conclusions:
- The generalizability of randomized drug trial results is substantially limited.
- Recommends detailed reporting of screening procedures in RCTs.
- Advocates for comparisons between randomized and excluded patient subgroups.